Dolutegravir and Lamivudine Tablets (50 mg + 300
Brand Name: TWINAQT®
Composition (Active Ingredients): Dolutegravir and Lamivudine Tablets (50 mg + 300 mg)
Manufacturer: Emcure®
Quantity: 30 Tablets
Product Description
Medical Info
TWINAQT® is a highly effective, dual-action antiretroviral medication manufactured by Emcure®. Each bottle contains 30 tablets, combining two powerful active ingredients: Dolutegravir (50 mg) and Lamivudine (300 mg). This fixed-dose combination therapy is prescribed to manage HIV-1 infection in adults and adolescents. By leveraging an integrase inhibitor alongside a nucleoside reverse transcriptase inhibitor, TWINAQT® efficiently suppresses viral replication, lowers the viral load, and strengthens the immune system. Developed under strict regulatory guidelines, it offers a simplified, once-daily single-tablet regimen that supports treatment adherence. Always consult a healthcare professional for proper clinical guidance.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
